Molidustat Sodium is mainly used to treat anemia in patients with chronic kidney disease (CKD), particularly those not on dialysis. It functions as a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), stimulating the body’s natural response to low oxygen levels and increasing the production of erythropoietin (EPO), a hormone that promotes red blood cell formation. This helps to alleviate the anemia often experienced by CKD patients due to reduced EPO production by the kidneys. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include molidustat oral and Musredo (TN). Its PubChem CID is 69669724.
Molidustat Sodium
| CAS No | 1375799-59-9 |
|---|---|
| Molecular Formula | C13H13N8NaO2 |
| Molecular Weight | 336.28 g/mol |
| Synonyms | sodium;2-(6-morpholin-4-ylpyrimidin-4-yl)-4-(triazol-1-yl)pyrazol-3-olate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Molidustat Sodium is mainly used to treat anemia in patients with chronic kidney disease (CKD), particularly those not on dialysis.
The listed CAS number is 1375799-59-9.
The listed molecular formula is C13H13N8NaO2.
The listed molecular weight is 336.28 g/mol.
sodium;2-(6-morpholin-4-ylpyrimidin-4-yl)-4-(triazol-1-yl)pyrazol-3-olate.
The source lists molidustat oral and Musredo (TN).